Diabetol Metab Syndr. 2026 Mar 29. doi: 10.1186/s13098-026-02151-x. Online ahead of print.
NO ABSTRACT
PMID:41906175 | DOI:10.1186/s13098-026-02151-x
Categories
Association of dual SGLT-2 inhibitor and GLP-1 receptor agonist therapy with colon cancer risk in post-polypectomy patients with diabetes: a target trial emulation
